When a stock breaks out of a well-formed base, you normally want to see the Relative Strength Rating exceed 80.

While the continued erosion of Biogen’s multiple sclerosis franchise and weaker-than-expected 2025 guidance doesn’t seem to ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...

Amazon isn't going to allow its arch rivals to dominate the headlines for AI investment. AWS's massive scale and highly ...

C3.ai, Inc. is riding the AI coattails from Palantir Technologies, but the relative value is remarkable. Click here to read ...

The Consumer Price Index (CPI) is set to be released in the second week of February on the morning of Wednesday. Investors ...

Microsoft (NASDAQ:MSFT) has delivered minimal gains over the past year and it has actually declined 1.61% year-to-date. This ...

The market is paying particularly close attention to Q4 earnings, given the S&P 500’s lofty valuation. Potential tariffs and ...

In the fast-paced world of investing, staying ahead requires good ideas and timely decisions. This article highlights five ...

We came across a bullish thesis on Microsoft Corporation (MSFT) on Substack by Long-term Investing. In this article, we will ...

Fourth-quarter earnings from McDonald’s fell short of analysts’ estimates but strength in total same-store sales lifted the ...

Goldman has previously explained that Phase 3 companies are those with the potential to monetize AI through generating incremental revenues, mostly in software and IT services. Phase 2 represents the ...